With the analysis among 26,195 patents, we discovered top 473 key players by total patent application. F. Hoffmann-La Roche Ltd., Novartis AG, Smithkline Beckman Corp are dominant in this area. They take 8.05% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Basel-Stadt, Switzerland
Patent: 718
Pennsylvania, United States
Patent: 493
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 487
Antwerpen, Belgium
Patent: 475
California, United States
Patent: 458
New York, United States
Patent: 426
Connecticut, United States
Patent: 413
New York, United States
Patent: 363
Elan Pharmaceuticals, LLC
Michigan, United States
Patent: 360
With the analysis among 366 patents, we discovered top 54 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Mitochon Pharmaceuticals, Inc., Cellix Bio Pvt Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Mitochon Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 32
Telangana, India
Patent: 28
Baden-Württemberg, Germany
Patent: 20
Utrecht, Netherlands
Patent: 18
Texas, United States
Patent: 14
AYUMI Pharmaceutical Corp.
Carrick Therapeutics Ltd.
Texas, United States
Patent: 8
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 8
With the analysis among related 3,877 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Eli Lilly & Co., Regeneron Pharmaceuticals, Inc., Janssen Pharmaceutica NV take 5.03% of patent filing during this period.
Indiana, United States
Patent: 90
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 64
Antwerpen, Belgium
Patent: 41
Basel-Stadt, Switzerland
Patent: 38
Illinois, United States
Patent: 37
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 35
Nordrhein-Westfalen, Germany
Patent: 24
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 21
Baden-Württemberg, Germany
Patent: 20
With the analysis among related 3,877 patents in last 5 years, we discover 241 new entrants. MeiraGTx UK II Ltd., HepaRegeniX GmbH, Modern Biosciences Ltd. are the most active new entrants in this area.
Baden-Württemberg, Germany
Patent: 20
Utrecht, Netherlands
Patent: 18
Virginia, United States
Patent: 18
Crystal Pharmaceutical (Suzhou) Co., Ltd
Jiangsu Sheng, China
Patent: 14
Glanis Pharmaceuticals, Inc.
Alberta, Canada
Patent: 14
Innovo Therapeutics Co. Ltd.
With the analysis among 4,220 patents, we discovered top 255 universities and scientific research institutions by total patent application. China Pharmaceutical University, Baylor College of Medicine, Queen Mary University of London are dominant in this area. They take 7.32% of the total patent filing.
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 65
Baylor College of Medicine
Texas, United States
Patent: 64
Queen Mary University of London
Connecticut, United States
Patent: 31
New York, United States
Patent: 31
North Carolina, United States
Patent: 30
The Scripps Research Institute
California, United States
Patent: 29
President & Fellows of Harvard College
Massachusetts, United States
Patent: 29
Regents of the University of Colorado
Colorado, United States
Patent: 29
Massachusetts, United States
Patent: 26